Skip to content
RuleResource Intelligence

← All developments

New York Attorney General · October 13, 2026 · Primary source

Attorney General James Urges Court to Punish Martin Shkreli for Brazenly Violating Lifetime Ban from Pharmaceutical Industry

Score 60PRIMARYregulatoryState AGNY

Summary

New York AG Letitia James joined the FTC and six other state AGs in filing a contempt motion in the U.S. District Court for the Southern District of New York against Martin Shkreli, alleging he violated the February 2022 permanent injunction banning him for life from the pharmaceutical industry by trading stocks in more than 60 pharmaceutical companies and livestreaming investment analysis on social media. The 2022 order, which also required Shkreli to pay nearly $65 million, followed a finding that he violated federal and state antitrust laws through the Daraprim price increase and generic suppression scheme at Vyera Pharmaceuticals. The coalition seeks divestiture of all pharmaceutical holdings, forfeiture of trading profits without loss offset plus interest, appointment of a court-paid auditor, and potential incarceration for continued violations.

What this may mean

The contempt proceeding targets a named individual subject to an existing court order and does not create new regulatory obligations for pharmaceutical companies, health plans, or providers. The case details, including Shkreli's use of social media livestreams to move pharmaceutical stock prices, are cited as evidence that public statements influencing pharmaceutical company business constitute prohibited 'participation' in the industry under the injunction, a definitional question the court's ruling will resolve.

Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.

Related items